Source: Inside Bigdata

MedyMatch: MedyMatch Reveals Artificial Intelligence Deep Vision Intracranial Bleed Detection Technology

MedyMatch Technology Ltd., ("MedyMatch") the deep learning and artificial intelligence company, announced that after several years of extensive research and development, it has achieved a major milestone in the availability, for research, of an artificial intelligence based technology that can help detect the presence of intracranial hemorrhage or brain bleed which can occur in cases of brain trauma and stroke. Subtle bleeds are difficult to detect and if misinterpreted or missed by a physician can lead to serious patient injury and even death.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Gene Saragnese's photo - Chairman & CEO of MedyMatch

Chairman & CEO

Gene Saragnese

CEO Approval Rating

50/100

Read more